BILL · 2019–20 SESSION

SB 5663: Drug compounding

Compounding drugs.

Summary

  • Exempts the following from the definition of "compounding" for purposes of chapter 18.64 RCW: Mixing, reconstitution, or other acts that are performed in accordance with directions contained in approved labeling provided by the product's manufacturer and other manufacturer directions consistent with that labeling.

From the Bill Digest (SB 5663), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · died in committee
  1. IntroducedJan 25, 2019
  2. Out of committeestopped here
  3. Passed Senate
  4. Passed House
  5. Governor
  6. Law
Prime sponsor
Annette Cleveland (D-49)
Introduced
January 25, 2019 in the Senate
Last action
January 13, 2020
Companion bill
HB 1352

AN ACT Relating to drug compounding;

Sponsors

Prime sponsor: Annette Cleveland (D-49)

1 co-sponsor (1 Democrat, 0 Republicans)

Votes

No recorded floor votes. This measure never reached a floor vote.

History

  1. By resolution, reintroduced and retained in present status.
  2. First reading, referred to Health & Long Term Care.

SB 5663 in other sessions

Bill numbers restart every two years, so the same number is a different bill in each session.

Report wrong or missing information on this page